Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3339737 | Allergologia et Immunopathologia | 2014 | 6 Pages |
Abstract
The presence of an underlying PID could explain the poor prognosis and refraction to the treatment of some patients with severe AD. Several clinical and laboratory findings can help the physicians to focus towards PIDs which are more serious. Delay in diagnosis of PID cases with skin manifestation of AD without proper management may result in lower quality of life and higher morbidity and mortality rates.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
A. Aghamohammadi, Z.Gholizadeh Moghaddam, H. Abolhassani, Z. Hallaji, H. Mortazavi, S. Pourhamdi, P. Mohammadinejad, N. Rezaei,